This prospective cross-sectional study included 70 patients with systemic sclerosis (SSc). The primary objective was to evaluate the association between nailfold videocapillaroscopy (NVC) patterns and clinical outcomes, including interstitial lung disease (ILD). Secondary outcomes assessed included skin fibrosis, autoantibody status, and patient-reported measures of quality of life and disability.
Advanced NVC patterns (classified as 4–5) were significantly associated with the presence of ILD. The odds ratio for this association was 3.73, with a 95% confidence interval of 1.42–9.81 (q = 0.0058). Additionally, higher NVC severity correlated with greater skin fibrosis, where the median modified Rodnan Skin Score (mRSS) increased from 4.0 in pattern 2 to 11.0 in pattern 5 (q = 0.0283).
Worse SSc Quality of Life (q = 0.0040), higher Health Assessment Questionnaire-Disability Index scores (q = 0.0027), and elevated pain and disease activity scores (q = 0.0040) were also observed with more severe NVC patterns. An inverse correlation was noted between NVC pattern severity and anti-Th/To antibody positivity (q = 0.022). Notably, exposure to cyclophosphamide or mycophenolate mofetil was associated with more severe capillaroscopic damage (q = 0.019 for both).
The study demonstrated diagnostic discrimination for ILD based on NVC pattern, with an area under the curve (AUC) of 0.688. However, the authors note that associations rather than causation were demonstrated. Specifically, exposure to cyclophosphamide or mycophenolate mofetil likely reflects greater underlying disease severity rather than a direct treatment effect. These limitations must be considered when interpreting the clinical relevance of NVC findings in this cohort.
View Original Abstract ↓
BackgroundCapillaroscopic patterns in systemic sclerosis (SSc) are routinely assessed by nailfold videocapillaroscopy (NVC), yet their broader clinical relevance remains incompletely defined.MethodsIn a prospective cross-sectional study of 70 SSc patients, we evaluated associations between NVC patterns and key clinical domains: interstitial lung disease (ILD), skin fibrosis (the modified Rodnan Skin Score, mRSS), SSc-specific autoantibody profile including anti-Th/To, immunosuppressive treatments, and patient-reported outcome measures (PROMs): SSc Quality of Life scale (SScQoL), Health Assessment Questionnaire-Disability Index (HAQ-DI), and Visual Analog Scales (VAS) for pain and disease activity (PtGA). Statistical methods included Spearman correlation, Mann–Whitney U-test, receiver operating characteristic (ROC) analysis, and logistic regression. p-values were adjusted using the false discovery rate (FDR).ResultsAdvanced NVC patterns (4–5) were significantly associated with ILD (OR = 3.73, 95% CI: 1.42–9.81, q = 0.0058), and this association remained consistent across multiple multivariable and parsimonious logistic regression models adjusting for anti-Scl-70 status, disease duration, or skin fibrosis (mRSS), with effect estimates around fourfold increased odds of ILD. ROC analysis demonstrated diagnostic discrimination for ILD based on NVC pattern (AUC = 0.688). Higher NVC severity was also associated with greater skin fibrosis (ρ = +0.38, q = 0.0283), with progressive increases in median mRSS from NVC pattern 2 to 5 (4.0 → 11.0). Strong associations were found with PROMs: worse SScQoL (q = 0.0040), higher HAQ-DI (q = 0.0027), and elevated PtGA (q = 0.0040). A novel inverse correlation was identified between NVC patterns and anti-Th/To antibody positivity (q = 0.022). Exposure to cyclophosphamide (CYC) or mycophenolate mofetil (MMF) was associated with more severe capillaroscopic damage (both q = 0.019) most likely reflecting greater disease severity rather than a treatment effect.ConclusionOur study demonstrates significant associations between NVC severity and selected clinical, serological, therapeutic, and patient-reported domains in SSc.